JPRN-UMIN000013858已完成2 期
phase II trial of concurrent chemoradiotherapy (CCRT) with docetaxel + cisplatin + cetuximab for locally advanced squamous cell carcinoma of the head and neck - Phase II trial of CCRT with TP + cetuximab regimen
Department of Biology and Function in the Head and Neck, Yokohama City University Graduate School of Medicine0 个研究点目标入组 30 人开始时间: 2014年5月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) with distant metastasis 2) nasopharyngeal cancer 3) post-operative chemoradiotherapy 4) with treatment history of cetuximab or with allergy to taxan, platinum analogue, or cetuximab or with a history of allergy 5) creatinin clearance < 65ml/min 6) with heart disease which is difficult to control 7) with interstitial pneumonitis or pulmonary fibrosis 8) with diabetic, hypertension, or liver dysfunction which is difficult to control 9) with infection which need to treat 10) with severe drug allergy 11) pregnant, women who like be pregnant, or man who doesn't agree to contraception during the treatment 12) doctor's decision not to be registered to this study
研究者
相似试验
已完成
2 期
Phase II study of Concurrent Chemoradiotherapy using Nedaplatin for Locally Advanced Uterine Cervical Carcinoma: Kitasato Gynecologic Radiation Oncology Group 0501 (KGROG0501)ocally Advanced Uterine Cervical CarcinomaJPRN-UMIN000025688Kitasato Gynecologic Radiatoin Oncology Group (KGROG)45
招募中
不适用
Clinical trial of concurrent chemoradiotherapy (CCRT) with S-1 in patients with advanced head and neck squamous cell carcinoma, who is not eligible for CCRT with Docetaxel, Cisplatin and 5-Fluorouracil (TPF) regimeadvanced head and neck squamous cell carcinomaJPRN-UMIN000021870Yokohama City University hospital40
已完成
2 期
A phase II trial of concurrent chemoradiotherapy with 5-FU plus cisplatin for resectable squamous cell carcinoma of cervical esophaguscervical esophageal cancerJPRN-UMIN000001439ational Cancer Center Hospital32
撤回
不适用
A Phase II Study of concurrent chemo-radiotherapy with Gemcitabine followed by chemotherapy with Gemcitabine and Cisplatin for unresectable localized perihilar cholangiocarcinomaNeoplasmsKCT0003478CC Hospital27
已完成
2 期
A phase II study of concurrent chemoradiotherapy with 5-fluorouracil and mitomycin-C for squamous cell carcinoma of the anal canalsquamous cell carcinoma of the anal canalJPRN-UMIN000012184Japanese Radiation Oncology Study Group40